HKIC, Gobi Partners and HKU team up for fund backing university research start-ups
Hong Kong Investment Corporation (HKIC), Gobi Partners, and the University of Hong Kong (HKU) have launched Gobi-HKU Fund I to invest in technology start-ups originating from HKU research. The fund, backed by government reserves managed by HKIC, aims to commercialize breakthroughs in areas like AI, robotics, and biotech.

Briefing Summary
AI-generatedHong Kong Investment Corporation (HKIC), Gobi Partners, and the University of Hong Kong (HKU) have launched Gobi-HKU Fund I to invest in technology start-ups originating from HKU research. The fund, backed by government reserves managed by HKIC, aims to commercialize breakthroughs in areas like AI, robotics, and biotech. At its launch, the fund invested in Manifold Tech (robotics) and AilsynBio (AI-driven drug design). HKIC utilizes a milestone approach, initially investing small amounts with potential for follow-on funding upon achieving commercialization targets. HKIC, established in 2022, manages HK$62 billion in government funds and aims to boost Hong Kong's economy and innovation industry through strategic investments and collaborations.
Article analysis
Model · rule-basedKey claims
5 extractedHKIC managed HK$62 billion (US$8 billion) in government funds and had invested in more than 190 projects as of February.
The fund used a milestone approach, meaning it would invest a small amount in individual projects initially.
Gobi-HKU Fund I made two investments at its launch: Manifold Tech and AilsynBio.
Hong Kong Investment Corporation, Gobi Partners and HKU team up for fund backing university research start-ups.
The fund is envisioned to help bring breakthroughs in AI, robotics, biotech and other critical sectors to the world.